Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc.

This chapter presents a historical perspective of the field of developmental toxicology and then an analysis of various mechanisms by which agents cause developmental toxicity, as currently understood ...

Metformin is an antidiabetic drug used in type 2 diabetes as well as indicators in polycystic ovary syndrome (PCOS) and cancer. Due to their increase in popularity, high amounts of metformin are being ...

The assessment of developmental toxicity in laboratory mammals is fundamental for evaluating the safety of chemicals, pharmaceuticals and environmental agents that may affect prenatal and postnatal ...

AMeD syndrome is a severe genetic condition found in children that present with accelerated aging, global developmental delay and bone marrow failure, among others, progressing to Myelodysplastic ...

The kidney plays a vital role in maintaining homeostasis within the body by eliminating toxic and superfluous substances in the bloodstream, including waste generated during metabolic processes, ...

Extensions to Thermo Scientific Cellomics Platform Address Comet and Zebrafish Applications Assessing the toxicity of a sample for its risk to human health is key throughout the life sciences. This ...

Change often involves a pivotal event that builds on previous history and opens the door to a new era. Pivotal events in science include the discovery of penicillin, the elucidation of the DNA double ...

WILMINGTON, Del. and COPENHAGEN, Denmark, April 9, 2026 /PRNewswire/ -- DeepCyte, a techbio company building AI toxicology tools for drug development, launched today with $1.5 million in seed funding.